Apellis Pharmaceuticals, Inc. (APLS): SCHEDULE 13D/A filed May 14, 2026

Form type
SCHEDULE 13D/A
Filing date
May 14, 2026
Accession number
0000950157-26-000611
Filer
Apellis Pharmaceuticals, Inc. (CIK 1492422)